---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-23-000059"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T02:33:16.429438+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Clover Health posts first quarterly Adjusted EBITDA profit of $10M; insurance MCR improves to 77.2%

## Summary
- Q2 revenue $513.6M; insurance revenue up 17% YoY to $314.4M; net loss $28.8M vs $104.4M loss YoY.
- Insurance MCR improved to 77.2% from 92.1% YoY; non-insurance MCR 99.6% vs 106.0%.
- Adjusted EBITDA profit $10.0M compared to loss of $83.9M in Q2 2022; first quarterly positive.
- FY 2023 guidance improved: insurance MCR 83%-85%, Adjusted EBITDA ($70M)-($120M).
- CEO Andrew Toy cites operational efficiencies and Clover Assistant R&D; CFO confident in FY 2024 EBITDA profitability without new capital.

## SEC filing metadata
- accession: 0001801170-23-000059
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000059/0001801170-23-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000059/clov-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-23-000059
- JSON: https://secwatch.observer/filing/0001801170-23-000059.json
- Plain text: https://secwatch.observer/filing/0001801170-23-000059.txt

## Key facts
- Earnings Releases
  CLOVER HEALTH INVESTMENTS, CORP. /DE reported the quarter ended June 30, 2023 results: revenue $513.6 million, net income $28.8 million. Guidance reaffirmed.
  - Period: the quarter ended June 30, 2023
  - Revenue: $513.6 million
  - Net income: $28.8 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: For the second quarter 2023, the Company reported revenue of $513.6 million and net loss of $28.8 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000059/0001801170-23-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.